Showing 5,061 - 5,080 results of 11,113 for search 'significantly ((((we decrease) OR (((nn decrease) OR (mean decrease))))) OR (observed decrease))', query time: 0.49s Refine Results
  1. 5061

    Assessing the impact of climate changes on the distribution of two corn diseases: corn stunt and corn reddening by José Carlos Barbosa Dos Santos (21993507)

    Published 2025
    “…We found that the most critical abiotic variables driving the global distribution of CS were: mean diurnal range, maximum temperature of the warmest month, and temperature seasonality. …”
  2. 5062

    Exploring <i>in vitro</i> anticancer potential of <i>Ferula gummosa</i> gum on PC-3 cells: insights from cellular and molecular studies by Negar Abdollahzadeh (20507068)

    Published 2025
    “…This resulted in mitochondrial membrane damage and the release of lactate dehydrogenase. Alongside this, we observed a decrease in intracellular ROS levels and a weakening of the mitochondrial membrane potential. …”
  3. 5063

    Supplementary file 1_Taxonomic and functional shifts in soil nematode communities following estuarine island reclamation.docx by Sufeng Pan (21460022)

    Published 2025
    “…We found a significant decrease in both taxonomic and functional diversity as tidal flats were converted to dry land, followed by a gradual recovery that progressed with increasing reclamation age. …”
  4. 5064

    Table4_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  5. 5065

    Image1_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.JPEG by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  6. 5066

    Table3_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  7. 5067

    Image2_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.JPEG by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  8. 5068

    Table1_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  9. 5069

    Image3_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.JPEG by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  10. 5070

    Table2_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  11. 5071

    Image 1_Shifting landscapes: dynamic changes from pro- to anti-inflammatory leukocyte phenotype in myocardial ischemia/reperfusion injury.jpeg by Pia Kröning (21623012)

    Published 2025
    “…A statitstically significant decrease in the percentage of anti-inflammatory Ly6C<sup>low</sup> PMCs was observed as early as day 3, when compared to the baseline value. …”
  12. 5072

    Image 2_Shifting landscapes: dynamic changes from pro- to anti-inflammatory leukocyte phenotype in myocardial ischemia/reperfusion injury.jpeg by Pia Kröning (21623012)

    Published 2025
    “…A statitstically significant decrease in the percentage of anti-inflammatory Ly6C<sup>low</sup> PMCs was observed as early as day 3, when compared to the baseline value. …”
  13. 5073

    Image 3_Shifting landscapes: dynamic changes from pro- to anti-inflammatory leukocyte phenotype in myocardial ischemia/reperfusion injury.jpeg by Pia Kröning (21623012)

    Published 2025
    “…A statitstically significant decrease in the percentage of anti-inflammatory Ly6C<sup>low</sup> PMCs was observed as early as day 3, when compared to the baseline value. …”
  14. 5074

    Image 4_Shifting landscapes: dynamic changes from pro- to anti-inflammatory leukocyte phenotype in myocardial ischemia/reperfusion injury.jpeg by Pia Kröning (21623012)

    Published 2025
    “…A statitstically significant decrease in the percentage of anti-inflammatory Ly6C<sup>low</sup> PMCs was observed as early as day 3, when compared to the baseline value. …”
  15. 5075

    Altering rRNA 2’O-methylation pattern during neuronal differentiation is regulated by FMRP by Michelle Ninochka D’Souza (22365912)

    Published 2025
    “…We found that FMRP influences a distinct rRNA 2’O-Methylation pattern across neuronal differentiation. …”
  16. 5076

    DataSheet1_Detecting centennial changes in the clarity and colour of the Red and Eastern Mediterranean Seas by retracing the “Pola” expeditions.pdf by Jonathan R. Heath (19465312)

    Published 2025
    “…The results show a significant greening of both regions investigated as well as a decrease in water clarity. …”
  17. 5077

    DataSheet2_Detecting centennial changes in the clarity and colour of the Red and Eastern Mediterranean Seas by retracing the “Pola” expeditions.csv by Jonathan R. Heath (19465312)

    Published 2025
    “…The results show a significant greening of both regions investigated as well as a decrease in water clarity. …”
  18. 5078

    Image1_AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics.TIF by Jingxia Du (8752482)

    Published 2024
    “…The results showed that AICAR, the AMPK activator, could significantly improve the function of left ventricular, decrease arrhythmia incidence and myocardial infarction area of isolated hearts. …”
  19. 5079

    DataSheet1_AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics.docx by Jingxia Du (8752482)

    Published 2024
    “…The results showed that AICAR, the AMPK activator, could significantly improve the function of left ventricular, decrease arrhythmia incidence and myocardial infarction area of isolated hearts. …”
  20. 5080

    Data Sheet 2_Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma.pdf by Robert B. Rebhun (8479020)

    Published 2025
    “…Cytotoxicity assays of PBMCs showed significant decreases after both surgery and chemotherapy with an overall decrease from the start to end of therapy (-18.2 ± 16.1%, P<0.001). …”